301 results on '"Bootsma, Marianne"'
Search Results
2. The arrhythmogenic cardiomyopathy phenotype associated with PKP2 c.1211dup variant
3. Left atrioventricular coupling index in hypertrophic cardiomyopathy and risk of new-onset atrial fibrillation
4. Effects of Left Bundle Branch Block and Pacemaker Implantation on Left Ventricular Systolic Function After Transcatheter Aortic Valve Implantation
5. QT interval variability and heart rate turbulence are associated with clinical characteristics in congenital heart disease patients with a systemic right ventricle
6. Association between reduced heart rate variability components and supraventricular tachyarrhythmias in patients with a systemic right ventricle
7. Reduced kinase function in two ultra‐rare TNNI3K variants in families with congenital junctional ectopic tachycardia
8. Prevalence and Prognostic Implications of Right Ventricular Dysfunction in Patients With Hypertrophic Cardiomyopathy
9. Chest pain in the absence of obstructive coronary artery disease: A critical review of current concepts focusing on sex specificity, microcirculatory function, and clinical implications
10. The Genetic Basis of Apparently Idiopathic Ventricular Fibrillation – a Retrospective Overview
11. Development of and Progression of Overt Heart Failure in Nonobstructive Hypertrophic Cardiomyopathy
12. One-Year Mortality in Patients Undergoing an Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy Pulse Generator Replacement: Identifying Patients at Risk
13. Temporal Relationship of Asystole to Onset of Transient Loss of Consciousness in Tilt-Induced Reflex Syncope
14. The genetic basis of apparently idiopathic ventricular fibrillation:A retrospective overview
15. Reclassification of a likely pathogenic Dutch founder variant in KCNH2:implications of reduced penetrance
16. Variant Location Is a Novel Risk Factor for Individuals with Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating Variant
17. The Genetic Basis of Apparently Idiopathic Ventricular Fibrillation - a Retrospective Overview
18. Variant Location Is a Novel Risk Factor for Individuals with Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating Variant
19. Importance of Systematic Diagnostic Testing in Idiopathic Ventricular Fibrillation
20. Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin ( DSP ) Truncating Variant
21. The Importance of Systematic Diagnostic Testing in Idiopathic Ventricular Fibrillation: Results From the Dutch iVF-Registry
22. Risk Stratification of Genetic, Dilated Cardiomyopathies Associated With Neuromuscular Disorders: Role of Cardiac Imaging
23. Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetrance
24. Sacral abnormalities including caudal appendage, skeletal dysplasia, and prenatal cardiomyopathy associated with a pathogenic TAB2 variant in a 3‐generation family
25. Peak and Fixed-Time High-Sensitive Troponin for Prediction of Infarct Size, Impaired Left Ventricular Function, and Adverse Outcomes in Patients With First ST-Segment Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention
26. Abstract 20814: High Rate of Atrial Arrhythmias in Individuals With Truncating Titin Mutations Including the First Dilated Cardiomyopathy Related Titin Founder Mutation
27. Abstract 19791: Prognostic Value of Right Ventricular Function in Patients With Hypertrophic Cardiomyopathy
28. Abstract 14880: Risk-stratification of Genetic Dilated Cardiomyopathy: Role of Deformation Imaging
29. Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy
30. Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy
31. Predictive power of T-wave alternans and of ventricular gradient hysteresis for the occurrence of ventricular arrhythmias in primary prevention cardioverter-defibrillator patients
32. Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetrance.
33. Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy.
34. Three-Year Outcome of Sirolimus-Eluting Versus Bare-Metal Stents for the Treatment of ST-Segment Elevation Myocardial Infarction (from the MISSION! Intervention Study)
35. Variant location is a novel risk factor for individuals with arrhythmogenic cardiomyopathy due to a desmoplakin (DSP) truncating variant
36. Stent Malapposition After Sirolimus-Eluting and Bare-Metal Stent Implantation in Patients with ST-Segment Elevation Myocardial Infarction: Acute and 9-Month Intravascular Ultrasound Results of the MISSION! Intervention Study
37. Regional Left Ventricular Myocardial Work Indices and Response to Cardiac Resynchronization Therapy
38. Chronic Kidney Disease and Implantable Cardioverter Defibrillator Related Complications: 16 Years of Experience
39. Five cases of complete atrioventricular block induced by bending forward: unusual but not unique
40. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Screening, diagnosis, and treatment
41. Arrhythmogenic Right Ventricular Dysplasia: MRI Findings
42. Imaging of an aneurysm of the sinus of Valsalva with transesophageal echocardiography, contrast angiography and MRI
43. Trans-venous lead removal without the use of extraction sheaths, results of >250 removal procedures
44. Mechanical extraction of cardiac implantable electronic devices leads with long dwell time: Efficacy and safety of the step up approach
45. Assessment of left atrial electro-mechanical delay to predict atrial fibrillation in hypertrophic cardiomyopathy
46. Right ventricular stimulation threshold at ICD implant predicts device therapy in primary prevention patients with ischaemic heart disease
47. Structured care for patients after acute myocardial infarction: sudden cardiac death prevention—data from the Leiden MISSION! AMI study
48. Patients with Scar-Related Right Ventricular Tachycardia: Determinants of Long-Term Outcome
49. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: Results from the Leiden MISSION! acute myocardial infarction treatment optimization program
50. Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.